Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Treasury Stock [Member] Retained Earnings [Member] Long-Lived Tangible Asset [Axis] Research Equipment and Software [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Furniture and Office Equipment [Member] Leasehold Improvements [Member] Cash and Cash Equivalents [Axis] Money Market Funds [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Other Money Market Funds [Member] US Treasury Securities [Member] Marketable Securities [Member] Convertible Loan Investment [Member] Award Type [Axis] 2013 Through December 31, 2020 [Member] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Israeli Innovation Authority [Member] Related Party [Axis] Technion Research and Development Foundation Limited [Member] Legal Entity [Axis] CardioSert Ltd [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] At-the-Market Offering Agreement [Member] H.C. Wainwright & Co. LLC [Member] Securities Purchase Agreement [Member] Alliance Investment Management, Ltd. [Member] Title of Individual [Axis] Joseph Mona [Member] Mr. Harel Gadot [Member] Employees Consultants and Directors [Member] Plan Name [Axis] Share Incentive Plan [Member] Employees and Directors [Member] Exercise Price Range [Axis] Exercise Price Ten [Member] Exercise Price One [Member] Exercise Price Two [Member] Exercise Price Three [Member] Exercise Price Four [Member] Exercise Price Five [Member] Exercise Price Six [Member] Exercise Price Seven [Member] Exercise Price Eight [Member] Exercise Price Nine [Member] Exercise Price Eleven [Member] Exercise Price Twelve [Member] Exercise Price Thirteen [Member] Exercise Price Fourteen [Member] Exercise Price Fifteen [Member] Exercise Price Sixteen [Member] Series A (2013) [Member] Series B (2016) [Member] Warrant to Underwriters 1/2019 [Member] Warrant to Underwriters 1/2019 One [Member] Warrant to Underwriters 12/2019 [Member] Warrant to Underwriters 12/2019 One [Member] Warrant to Underwriters 12/2019 Two [Member] Auction Market Preferred Securities, Stock Series [Axis] Series A and B Warrants [Member] Antidilutive Securities [Axis] Warrant [Member] Income Statement Location [Axis] Research and Development Expense [Member] General and Administrative Expense [Member] Income Tax Authority, Name [Axis] Israel Tax Authority [Member] U.S. Tax Authority [Member] Geographical [Axis] ISRAEL UNITED STATES Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] ICFR Auditor Attestation Flag Auditor Firm ID Auditor Name Auditor Location Statement of Financial Position [Abstract] ASSETS Current assets: Cash and cash equivalents Marketable securities Restricted cash Prepaid expenses and other assets Total current assets Property and equipment, net Operating right-of-use assets Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payables Lease liabilities Accrued liabilities Total current liabilities Non current liabilities: Long-term lease liabilities Total liabilities Commitments and contingencies Stockholders’ equity: Common stock; $0.01 par value; 60,000,000 shares authorized as of December 31, 2021 and 2020; 7,108,133 shares issued and outstanding as of December 31, 2021 and 2020 Additional paid-in capital Accumulated deficit Total stockholders’ equity Total liabilities and stockholders’ equity Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Research and development General and administrative Operating loss Financing income (expenses), net Net loss Basic and diluted net loss per share Basic and diluted weighted average common shares outstanding Statement [Table] Statement [Line Items] Balance Balance, shares Share-based compensation Exercise of options Exercise of options, Shares Cancellation of treasury Common Stock Cancellation of treasury Common Stock, Shares Net loss Balance Balance, shares Statement of Cash Flows [Abstract] Operating activities: Adjustments to reconcile net loss to net cash flows from operating activities: Depreciation and amortization Unrealized gain from convertible loan Non-cash and accrued interest Share-based compensation expense Changes in assets and liabilities: Prepaid expenses and other assets Other payables and accrued liabilities Net cash flows from operating activities Investing activities: Purchase of property and equipment Investment in convertible loan Proceeds from sale of investment Purchase of marketable securities Proceeds from sales of marketable security Net cash flows from investing activities Financing activities: Repayment of shareholders investment Net cash flows from financing activities Decrease in cash, cash equivalents and restricted cash Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at ending of period Supplemental disclosure of cash flow information: Interest paid from litigation Cash received from interest Right-of-use assets and lease liability Organization, Consolidation and Presentation of Financial Statements [Abstract] GENERAL Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Fair Value Disclosures [Abstract] FAIR VALUE MEASUREMENTS Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] OTHER CURRENT ASSETS Leases LEASES Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT, NET Payables and Accruals [Abstract] ACCRUED LIABILITIES Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Equity [Abstract] SHARE CAPITAL Earnings Per Share [Abstract] BASIC AND DILUTED NET LOSS PER SHARE Research and Development [Abstract] RESEARCH AND DEVELOPMENT EXPENSES, NET General And Administrative Expenses GENERAL AND ADMINISTRATIVE EXPENSES Related Party Transactions [Abstract] TRANSACTIONS AND BALANCES WITH RELATED PARTIES Income Tax Disclosure [Abstract] TAXES ON INCOME Basis of presentation: Financial statement in U.S. dollars: Principles of consolidation: Cash and cash equivalents: Restricted cash: Fair value of financial instruments: Concentrations of credit risk Property and equipment: Liabilities due to termination of employment agreements: Basic and diluted net loss per share: Research and development expenses, net: Share-based compensation: Income Taxes: Marketable securities: Leases Contingencies Recently issued accounting pronouncements Recently issued accounting pronouncements not yet adopted ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT SCHEDULE OF FAIR VALUE MEASUREMENT INPUTS AND VALUATION TECHNIQUES SCHEDULE OF OTHER CURRENT ASSETS SCHEDULE OF SUPPLEMENTAL CASH FLOW INFORMATION RELATED TO OPERATING LEASES SCHEDULE OF MATURITIES OF LEASE LIABILITIES SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES SUMMARY OF PROPERTY AND EQUIPMENT, NET SUMMARY OF ACCRUED LIABILITIES SUMMARY OF STOCK OPTION ACTIVITY SCHEDULE OF STOCK OPTIONS OUTSTANDING SCHEDULE OF STOCK OPTIONS VALUATION ASSUMPTIONS SCHEDULE OF WARRANTS OUTSTANDING SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES EXCLUDED FROM DILUTED LOSS PER SHARE SCHEDULE OF RESEARCH AND DEVELOPMENT EXPENSES SCHEDULE OF GENERAL AND ADMINISTRATIVE EXPENSES SCHEDULE OF RELATED PARTY TRANSACTION AND BALANCES SCHEDULE OF DEFERRED TAX ASSETS SCHEDULE OF STATUTORY CORPORATE TAX RATE AND EFFECTIVE INCOME TAX RATE Unrestricted cash and cash equivalent Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property, plant and equipment, useful life Property, plant and equipment, useful life Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Assets, fair value Amounts due from government institutions Convertible loan investment Prepaid expenses others Total Other current assets Schedule Of Supplemental Cash Flow Information Related To Operating Leases Cash payments for operating leases Schedule Of Maturities Of Lease Liabilities 2022 2023 2024 2025 Total future lease payments Less imputed interest Total lease liability balance Operating leases weighted average remaining lease term (in years) Operating leases weighted average discount rate Short-term lease term Lease payment Issued bank guarantee Cost Accumulated Depreciation Net book value Employee-related liabilities Other current liabilities Total Accrued Liabilities Loss Contingencies [Table] Loss Contingencies [Line Items] Total grants obtained Royalties payable as percentage of future sales Initial payment Number of common shares acquired Number of common shares acquired, value Investments Buy back amount per patent Monthly consultation fee Monthly consultation fee in USD Currency exchange rate, description Common stock par value Offering costs Settlement amount Number of post-stock split shares returned Purchase price of plaintiffs Litigation settlement Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items] Number of stock options outstanding, Outstanding at beginning of period Weighted average exercise price, Outstanding at beginning of period Number of stock options outstanding, Granted Weighted average exercise price, Granted Number of stock options outstanding, Excercise Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Number of stock options outstanding, Forfeited Weighted average exercise price, Forfeited Number of stock options outstanding, Outstanding at end of period Weighted average exercise price, Outstanding at end of period Number of stock options outstanding, Vested at end of period Weighted average exercise price, Vested at end of period Share-based Payment Arrangement, Option, Exercise Price Range [Table] Share-based Payment Arrangement, Option, Exercise Price Range [Line Items] Exercise price Stock options outstanding Weighted average remaining contractual life Stock options exercisable Expected volatility, minimum Expected volatility, maximum Risk-free interest, minimum Risk-free interest, maximum Dividend yield Expected terms (years) Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Number of outstanding warrants Exercise price Exercisable Through Number of stock options granted Weighted-average exercise price per share, granted Stock option vested term Stock-based employee compensation Aggregate intrinsic value of outstanding options Aggregate intrinsic value of exercisable options Unrecognized compensation costs, net of expected forfeitures Unrecognized compensation weighted average period Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Potentially dilutive securities excluded from diluted loss per share Payroll and related expenses Share-based compensation Professional services Materials Patents Rent Office and maintenance expenses Depreciation Other Research and development expense Government fees Insurance Public and investor relations Travel Other General and administrative expenses ESOP expenses to CEO and executive officers Directors fees ESOP expenses to directors Insurance Total Other accounts payable Net operating loss carry-forward Total deferred tax assets Valuation allowance Net deferred tax assets Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Table] Significant Change in Unrecognized Tax Benefits is Reasonably Possible [Line Items] Statutory tax rate Income Tax under statutory tax rate Change in valuation allowance Actual provision for income taxes Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Corporate income tax rate Operating Loss Carryforwards Cancellation of treasury shares. Stock Cancellation Shares Of Treasury Shares. Non cash and accrued interest Repayment of share holders investment Interest paid from litigation Unrealized gain from convertible loan. Unrestricted cash and cash equivalent. Recently Issued Accounting Pronouncements Not Yet Adopted [Policy Text Block] Schedule Of Property And Equipment Useful Lives [Table Text Block] Research Equipment and Software [Member] Furniture And Office Equipment [Member] Other Money Market Funds [Member] Marketable Securities [Member] Convertible Loan Investment [Member] Convertible loan Investment. Schedule Of Supplemental Cash Flow Information Related To Operating Leases [Table Text Block] Schedule Of Supplemental Information Related To Leases [Table Text Block] Israeli Innovation Authority [Member] Net sales royalty percentage. Technion Research And Development Foundation Limited [Member] CardioSert Ltd [Member] Buy back amount per patent. Monthly consultation fee in USD. Currency exchange rate, description. At-the-Market Offering Agreement [Member] H.C. Wainwright & Co. LLC [Member] Offering costs. Securities Purchase Agreement [Member] Number of post-stock split shares returned. Alliance Investment Management, Ltd. [Member] Joseph Mona [Member] Mr. Harel Gadot [Member] General And Administrative Expenses [Text Block] Schedule of General and Administrative Expense [Table Text Block] Office and maintenance expenses. The amount of expense provided in the period for government service fees. Amount of general and administrative expense related to public and investor relation. Insurance related party. Employee stock ownership plan expenses to directors related party. Employee stock ownership plan expenses to chief executive officer and executive officers related party. U.S. Tax Authority [Member] Board of Directors [Member] Share Incentive Plan [Member] Employees and Directors [Member] Exercise Price Ten [Member]. Exercise Price One [Member] Exercise Price Two [Member] Exercise Price Three [Member] Exercise Price Four [Member] Exercise Price Five [Member] Exercise Price Six [Member] Exercise Price Seven [Member] Exercise Price Eight [Member] Exercise Price Nine [Member] Exercise Price Eleven [Member] Exercise Price Twelve [Member] Exercise Price Thirteen [Member] Exercise Price Fourteen [Member] Exercise Price Fifteen [Member] Exercise Price Sixteen [Member] Class of warrant or righst month year from which warrants or rights exercisable. Warrant to Underwriters 12.2019 Two [Member] Series A (2013) [Member] Series B (2016) [Member] Warrant to Underwriters 1.2019 [Member] Warrant to Underwriters 1.2019 One [Member] Warrant to Underwriters 12.2019 One [Member] Warrant to Underwriters 12.2019 [Member] Series A and B Warrants [Member] Proceeds from sales of investment. Bank gurantee issued. 2013 Through December 31, 2020 [Member] Employees Consultants and Directors [Member] Assets, Current Assets Liabilities, Current Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Research and Development Expense General and Administrative Expense Operating Income (Loss) Shares, Outstanding UnrealizedGainFromConvertibleLoan Increase (Decrease) in Prepaid Expense and Other Assets Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Payments to Acquire Other Investments Payments to Acquire Marketable Securities Net Cash Provided by (Used in) Investing Activities RepaymentOfShareholdersInvestment Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Lessee, Leases [Policy Text Block] Property, Plant and Equipment, Estimated Useful Lives Other Assets, Current Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Class of Warrant or Right, Exercise Price of Warrants or Rights Other General and Administrative Expense InsuranceRelatedParty Costs and Expenses, Related Party Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance